Literature DB >> 24139479

Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.

Eun Ae Cho, Won-Young Choi, Seung-Hun Kim, Ji-Yun Hong, Sung-Hoon Jung, Min-Jee Kim, Jun-Eul Hwang, Woo-Kyun Bae, Hyun-Jeong Shim, Kyung-Hwa Lee, Sang-Hee Cho, Ik-Joo Chung.   

Abstract

Primary angiosarcoma of the spleen is an extremely rare malignancy. Splenic angiosarcoma is difficult to diagnose, and treatment is often challenging. The prognosis is dismal, with a mean survival of less than 1 year. Currently, no standard treatment methods have been established. Anecdotal reports suggest that early diagnosis and prompt splenectomy followed by cytotoxic chemotherapy can be effective treatment modalities. We report a case of rapidly progressing primary splenic angiosarcoma with multiple liver and bone metastases and a fatal hemorrhagic outcome.

Entities:  

Keywords:  Angiosarcoma,; Chemotherapy; Spleen,; Splenectomy,

Mesh:

Year:  2013        PMID: 24139479     DOI: 10.1179/1973947813Y.0000000146

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  12 in total

Review 1.  Angiosarcoma.

Authors:  Robin J Young; Nicola J Brown; Malcolm W Reed; David Hughes; Penella J Woll
Journal:  Lancet Oncol       Date:  2010-05-25       Impact factor: 41.316

2.  [Primary angiosarcoma of the spleen].

Authors:  M Alvite Canosa; L Alonso Fernández; M Seoane Vigo; M Berdeal Díaz; J Pérez Grobas; A Bouzón Alejandro; M Carral Freire; P de Llano Monelos; C Gómez Freijoso
Journal:  Rev Esp Enferm Dig       Date:  2008-06       Impact factor: 2.086

3.  Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Authors:  Nicolas Penel; Binh Nguyen Bui; Jacques-Olivier Bay; Didier Cupissol; Isabelle Ray-Coquard; Sophie Piperno-Neumann; Pierre Kerbrat; Charles Fournier; Sophie Taieb; Marta Jimenez; Nicolas Isambert; Frédéric Peyrade; Christine Chevreau; Emmanuelle Bompas; Etienne G C Brain; Jean-Yves Blay
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

4.  Primary angiosarcoma of the spleen.

Authors:  Jun-Te Hsu; Han-Ming Chen; Chin-Yew Lin; Chun-Nan Yeh; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Surg Oncol       Date:  2005-12-15       Impact factor: 3.454

5.  Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT.

Authors:  B Mahony; R B Jeffrey; M P Federle
Journal:  AJR Am J Roentgenol       Date:  1982-05       Impact factor: 3.959

6.  Angiosarcoma of the spleen: imaging characteristics in 12 patients.

Authors:  William M Thompson; Angela D Levy; Nadine S Aguilera; Luis Gorospe; Robert M Abbott
Journal:  Radiology       Date:  2005-03-04       Impact factor: 11.105

7.  Primary hemangiosarcoma of the spleen associated with leukocytosis and abnormal spleen scan.

Authors:  P Montemayor; V Caggiano
Journal:  Int Surg       Date:  1980 Jul-Aug

8.  Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases.

Authors:  S Falk; J Krishnan; J M Meis
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

9.  [Angiosarcoma as a rare differential diagnosis in spontaneous rupture of the spleen].

Authors:  A Maier; F Bataille; D Krenz; M Anthuber
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

10.  Primary splenic angiosarcoma.

Authors:  Kamran S Hamid; Joaquin A Rodriguez; Terry C Lairmore
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

View more
  1 in total

1.  Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review.

Authors:  Dan Pan; Tai-Ping Li; Jian-Hui Xiong; Shu-Bo Wang; Yao-Xu Chen; Jian-Feng Li; Qi Xiao
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.